No Data
No Data
joincare pharmaceutical group industry (600380.SH) plans to sell some real estate, involving the Zhuhai Health Industry Base, a fundraising project for the 2018 rights issue.
Joincare Pharmaceutical Group Industry (600380.SH) announced that its wholly-owned subsidiary, Joincare Pharmaceutical (China) Co., Ltd., plans to transfer its holdings...
Joincare Pharmaceutical Group Industry (600380.SH): Its subsidiary Health China plans to transfer the rights to use land and its ground buildings.
Joincare Pharmaceutical Group Industry (600380.SH) announced on September 10th that in order to improve the efficiency of fund utilization and further optimize the company's assets, its wholly-owned subsidiary, Health China, plans to transfer the state-owned land use rights and the ground building located on the south side of Hubin Road and the east side of Binhe Road in Sanzao Town, Jinwan District, Zhuhai City, with a land area of 94,538 square meters, to Yangyi Biology for a transfer price of 79.52 million yuan (including taxes). The subject of this transaction involves the construction project of the Zhuhai Health China Industrial Base, a capital increase and investment project in 2018. This transaction is beneficial for revitalizing the company's existing assets.
Gigadevice Semiconductor Inc.: Intends to repurchase shares of 1.5 billion yuan-2 billion yuan; Joincare Pharmaceutical Group Industry: Intends to spend 3 billion yuan-5 billion yuan to repurchase shares.
[Company Business Data] *ST Hanma (600375.SH): In mid-August, the sales volume of heavy trucks was 665 units, a year-on-year increase of 4.56%. Ningbo Zhoushan Port (601018.SH): The expected cargo throughput in August is 97.85 million tons, a year-on-year increase of 4.9%. Dongan Power (600178.SH): The total engine sales in August amounted to 25,728 units, a year-on-year decrease of 26.43%. [Contracted Projects] ST Haoyuan (002700.SZ): Intends to purchase office buildings in the Jinlan Square community in Aksu City for 16.74 million yuan. Ningbo Gaofa (603788.SH): Intends to establish a wholly-owned subsidiary in Singapore.
Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Share Price Is Matching Sentiment Around Its Earnings
Joincare Pharmaceutical Group Industry (600380.SH): The director proposed to buy back the company's shares.
Joincare Pharmaceutical Group Industry (600380.SH) announced on August 26th that based on confidence in the company's future prospects and recognition of the company's value, Mr. Zhu Baoguo, the actual controlling shareholder and chairman of the company, proposed that the company repurchase its ordinary shares (A shares) denominated in renminbi through the Shanghai Stock Exchange trading system by means of centralized bidding trading, with a total repurchase amount of no less than RMB 300 million (inclusive) and no more than RMB 500 million (inclusive).
Joincare Pharmaceutical Group Co., Ltd. 2024 Semi-Annual Report (English Version)
No Data
No Data